Decreased plasma peptide YY accompanied by elevated peptide YY and Y2 receptor binding densities in the medulla oblongata of diet-induced obese mice

Endocrinology

Volumn 148, Issue 10, 2007, Pages 4704-4710

  Rahardjo, Gita L ^a   Huang, Xu Feng ^a   Yean, Yeow Tan ^b   Deng, Chao ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b SCHIZOPHRENIA RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE YY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BODY COMPOSITION; C57BL 6 MOUSE; CALORIC INTAKE; CONTROLLED STUDY; DIET; ENERGY BALANCE; HYPOTHALAMUS; LIPID DIET; LOW FAT DIET; MEDULLA OBLONGATA; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; STATISTICAL ANALYSIS; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; AUTORADIOGRAPHY; BODY WEIGHT; DIET, FAT-RESTRICTED; DIETARY FATS; DISEASE SUSCEPTIBILITY; ENERGY INTAKE; HYPOTHALAMUS; MEDULLA OBLONGATA; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; PEPTIDE YY; RECEPTORS, NEUROPEPTIDE Y;

EID: 34748881759     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0107     Document Type: Article

References (43)

1. Taylor IL 1989 Pancreatic polypeptide family: pancreatic polypeptide, neuropeptide Y, and peptide YY. In: Soc AP, ed. Handbook of physiology, the gastrointestinal system, neural and endocrine biology. Baltimore, MD Williams & Wilkins; 475-544
2. Vrang N, Madsen AN, Tang-Christensen M, Hansen G, Larsen PJ 2006 PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol 291:R367-R375
3. Feinle-Bisset C, Patterson M, Ghatei MA, Bloom SR, Horowitz M 2005 Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol 289:E948-E953
4. Pilichiewicz AN, Little TJ, Brennan IM, Meyer JH, Wishart JM, Otto B, Horowitz M, Feinle-Bisset C 2006 Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol 290:R668-R677
5. Chelikani PK, Haver AC, Reidelberger RD 2004 Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. Am J Physiol 287:R1064-R1070
6. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR 2002 Gut hormone PYY3-36 physiologically inhibits food intake. Nature 418:650-654
7. McGowan BMC, Bloom SR 2004 Peptide YY and appetite control. Curr Opin Pharmacol 4:583-588
8. Chen CH, Stephens RL, Rogers RC 1997 PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC. Neurogastroenterol Motil 9:109-116
9. Batterham RL, Bloom SR 2003 The gut hormone peptide YY regulates appetite. Ann NY Acad Sci 994:162-168
10. Konturek SJ, Konturek JW, Pawlik T, Brzozowki T 2004 Brain-gut axis and its role in the control of food intake. J Physiol Pharmacol 55:137-154
11. le Roux CW, Bloom SR 2005 Peptide YY, appetite and food intake. Proc Nutr Soc 64:213-216
12. Renshaw D, Batterham RL 2005 Peptide YY: a potential therapy for obesity. Current Drug Targets 6:171-179
13. Chen CH, Rogers RC 1997 Peptide YY and the Y-2 agonist PYY-(13-36) inhibit neurons of the dorsal motor nucleus of the vagus. Am J Physiol 42:R213-R218
14. Hernandez EJ, Whitcomb DC, Vigna SR, Taylor IL 1994 Saturable binding of circulating peptide Yy in the dorsal vagal complex of rats. Am J Physiol 266:G511-G516
15. Huang X-F, Han M, Storlien LH 2003 The level of NPY receptor mRNA expression in diet-induced obese and resistant mice. Mol Brain Res 115:21-28
16. Lin S, Thomas TC, Storlien LH, Huang XF 2000 Development of high fat diet-induced obesity and leptin resistance in C57BL/6J mice. Int J Obes Relat Metab Disord 24:639-646
17. Dobush GR, Ankney CD, Krementz DG 1985 The effect of apparatus, extraction time, and solvent type on lipid extractions of snow geese. Can J Zool 63:1917-1920
18. Dumont Y, Fournier A, Stpierre S, Quirion R 1993 Comparative characterization and autoradiographic distribution of neuropeptide-Y receptor subtypes in the rat brain. J Neurosci 13:73-86
19. Lin S, Boey D, Couzens M, Lee N, Sainsbury A, Herzog H 2005 Compensatory changes in [125I]-PYY binding in Y receptor knockout mice suggest the potential existence of further Y receptor(s). Neuropeptides 39:21-28
20. Huang X-F, Huang X, Han M, Chen F, Storlien L, Lawrence AJ 2004 5-HT2A/2C receptor and 5-HT transporter densities in mice prone or resistant to chronic high-fat diet-induced obesity: a quantitative autoradiography study. Brain Res 1018:227-235
21. Paxinos G, Franklin KBJ 2003 The mouse brain in stereotaxic coordinates. 2nd ed. Sydney: Academic Press
22. Boey D, Heibronn L, Sainsbury A, Laybutt R, Kriketo A, Herzog H, Campbell LV 2006 Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides 41:317-324
23. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein VE, Reeve JR 1994 Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept 51:151-159
24. Sainsbury A, Schwarzer C, Couzens M, Fetissov S, Furtinger S, Jenkins A, Cox HM, Sperk G, Hokfelt T, Herzog H 2002 Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 99:8938-8943
25. Barraco RA, Ergene E, Dunbar JC, Ganduri YL, Anderson GF 1991 Y2 receptors for neuropeptide Y in the nucleus of the solitary tract mediate depressor responses. Peptides 12:691-698
26. Dumont Y, Fournier A, St. Pierre S, Quirion R 1996 Autoradiographic distribution of I-125 Leu(31), Pro(34) PYY and I-125 PYY3-36 binding sites in the rat brain evaluated with two newly developed Y-1 and Y-2 receptor radioligands. Synapse 22:139-158
27. Playford RJ, Benito-Orfila MA, Nihoyannopoulos P, Nandha KA, Cockcroft J, Todd S, Ghatei MA, Domin J, Bloom SR, Calam J 1992 Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide. Am J Physiol 263:E740-E747
28. Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JRS 1999 Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 20:1099-1105
29. Bunag R, Eriksson L, Krizsan D 1990 Baroreceptor reflex impairment and mild hypertension in rats with dietary-induced obesity. Hypertension 15:397-406
30. Bunag RD, Krizsan D, Itoh H 1990 Diminished cardiovascular responsiveness to vagal stimulation in obese rats. Am J Physiol 259:R842-R848
31. Lohmeier TE, Warren S, Cunningham JT 2003 Sustained activation of the central baroreceptor pathway in obesity hypertension. Hypertension 42:96-102
32. le Roux CW, Batterham RL, Aylwin SJB, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, Bloom SR 2006 Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147:3-8
33. Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, Couzens M, Slack K, Dallmann R, Sainsbury A, Herzog H 2006 Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49:1360-1370
34. Stock S, Leichner P, Wong ACK, Ghatei MA, Kieffer TJ, Bloom SR, Chanoine JP 2005 Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 90:2161-2168
35. Chelikani PK, Haver AC, Reeve JR, Keire DA, Reidelberger RD 2006 Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats. Am J Physiol 290:R298-R305
36. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR 2003 Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941-948
37. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, Le Roux CW, Thomas EL, Bell JD, Withers DJ 2006 Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 4:223-233
38. Broome M, Hokfelt T, Terenius L 1985 Peptide YY (PYY)-immunoreactive neurons in the lower brain stem and spinal cord of rat. Acta Physiol Scand 125:349-352
39. Ekman R, Wahlestedt C, Bottcher G, Sundler F, Hakanson R, Panula P 1986 Peptide YY-like immunoreactivity in the central nervous system of the rat. Regul Pept 16:157-168
40. Huda MSB, Wilding JPH, Pinkney JH 2006 Gut peptides and the regulation of appetite. Obes Rev 7:163-182
41. Murphy KG, Bloom SR 2004 Gut hormones in the control of appetite. Exp Physiol 89:507-516
42. Tschop M, Castaneda TR, Joost HG, Thone-Reineke C, Ortmann S, Klaus S, Hagan MM, Chandler PC, Oswald KD, Benoit SC, Seeley RJ, Kinzig KP, Moran TH, Beck-Sickinger AG, Koglin N, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Schindler M, Arndt K, Rudolf K, Mark M, Deng XY, Withcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Craney S, Flora D, Smiley D, Heiman ML 2004 Physiology: does gut hormone PYY3-36 decrease food intake in rodents? Nature 430:1- 4
43. Kanatani A, Mashiko S, Murai N, Sugimoto N, Ito J, Fukuroda T, Fukami T, Morin N, MacNeil DJ, Van der Ploeg LHT, Saga Y, Nishimura S, Ihara M 2000 Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice. Endocrinology 141:1011-1016